Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

If Trump continues to defy judges, and Congress remains pliant, then our constitutional form of government is essentially ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a research ...

Veteran Opera Theatre St. Louis attendees have known Brownlee for decades; as a Gerdine Young Artist in 1999 and 2000, he ...

AlphaQuest LLC lowered its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 73.9% during the 4th quarter, ...

New York, New York-- (Newsfile Corp. - March 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...

Dissidents resisting authoritarian regimes should be independent of the United States—and so should their media sources.

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...

Uncover the significance of ground surfaces in architecture and their role in shaping personal and collective spatial ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Pliant Therapeutics To Contact Him Directly To Discuss Their Options If ...

President Trump’s nominee to run the FDA secured the Senate HELP Committee’s backing. Elsewhere, Sutro cut jobs and a cell ...